ArticleVeterinary world2025
Gamma-oryzanol supplementation enhances laying performance, egg quality, and ovarian follicular development in Japanese quails.
Article in Veterinary world, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Gamma-oryzanol, a bioactive compound derived from rice bran, is recognized for its antioxidant and metabolic regulatory properties. This study evaluated the effects of dietary gamma-oryzanol supplementation on laying performance, egg quality, blood health, and follicular development in Japanese quails ( Materials and Methods: A total of 216 12-week-old laying quails were randomly assigned to six groups receiving -gamma-oryzanol at 0 (control), 0.1, 0.2, 0.3, 0.4, and 0.5 g/kg of diet for 7 weeks. Feed intake, egg production, feed conversion ratio, egg quality traits, hematological and biochemical parameters, and ovarian follicular characteristics were measured. Statistical analysis was conducted using one-way analysis of variance and Duncan's Results: Gamma-oryzanol at 0.2 g/kg significantly increased egg production (98.69%) compared to the control (86.80%). Supplementation at 0.3-0.5 g/kg improved eggshell thickness and yolk index (p < 0.05). Red blood cell counts were significantly higher at 0.4 g/kg, indicating enhanced erythropoiesis. Other hematological and biochemical parameters remained unchanged. A significant increase in small white follicle count and F3 follicle diameter was observed at 0.5 g/kg, indicating improved follicular development. Conclusion: Gamma-oryzanol supplementation at 0.2-0.5 g/kg enhanced laying performance, egg quality, and ovarian follicle development without adverse hematological or biochemical effects. The compound shows potential as a safe and functional feed additive to support productivity and reproductive efficiency in commercial quail production.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.